Phibro Animal Health | PAHC - L'Utile Operativo





L'Utile Operativo Cambiamento Data
Align Technology USD 224.71M 40.06M 2025-12
ANI Pharmaceuticals USD 29.13M 6.3M 2025-12
Assertio Holdings USD -3.05M 569K 2024-09
Aurora Cannabis CAD -35.79M 19.88M 2025-12
Bristol-Myers Squibb USD 4.2B 562M 2025-12
Canopy Growth CAD -12.66M 1.64M 2025-12
Corcept Therapeutics USD 4.49M 5.73M 2025-12
Eli Lilly USD 8.99B 599.9M 2025-12
Henry Schein USD 186M 12M 2025-12
Idexx Laboratories USD 315.6M 39.24M 2025-12
Knight Therapeutics CAD 6.21M 3.27M 2025-12
Merck USD 6.24B 318M 2025-12
Nektar Therapeutics USD -34.34M 15.43M 2024-09
Pacira USD 3.19M 9.96M 2025-12
Phibro Animal Health USD 54.99M 2.36M 2025-12
Prestige Brands USD 82.49M 2.82M 2025-12
Supernus Pharmaceuticals USD 13.82M 74.01M 2025-12
Zoetis USD 835M 101M 2025-12